Pulmonary hypertension: NO therapy?

Thorax

Volumn 51, Issue 7, 1996, Pages 762-764

  Adnot, Serge ^a   Raffestin, Bernadette ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Endothelium; Nitric oxide; Pulmonary hypertension

Indexed keywords

NITRIC OXIDE;

DRUG ACTIVITY; DRUG EFFICACY; HUMAN; MEDICAL RESEARCH; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SHORT SURVEY; VASODILATATION;

EID: 0029931761     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.51.7.762     Document Type: Short Survey

References (13)

1. Moncada S, Palmer R, Higgs E. Nitric oxide: physiology, pathophysinlogy and pharmacology. Pharmacol Rev 1991; 43:109-42.
2. Tuder R, Flook B, Voelkel N. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J Clin Invest 1995;95: 1798-807.
3. Kourembanas S, McQuillan LP, Leung GK, Faller DV. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J Clin Invest 1993;92:99-104.
4. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA, et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995;96:60-8.
5. Dinh Xuan AT, Higenbottam TW, Clelland CA, Pepke-zaba J, Cremona G, Butt AY, et al. Impairment of endothelium-dependent pulmonary artery relaxation in chronic obstructive lung disease. N Engl J Med 1991;324:1539-47.
6. Adnot S, Raffestin B, Eddahibi S, Braquet P, Chabrier PE. Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J Clin Invest 1991;87:155-62.
7. Fineman J, Wong J, Morin F, Wild L, Soifer S. Chronic nitric oxide inhibition in utero produces persistent pulmonary hypertension in newborn lambs. J Clin Invest 1994;93: 2675-83.
8. Zapol W, Rimar S, Gillis N, Marletta M, Bosken C. Nitric oxide and the lung. Am J Respir Crit Care Med 1994;149: 1375-80.
9. Palevski HI, Long W, Crow J, Fishman AP. Prostacyclin and acetylcholine as screening agents for acute pulmonary vasodilator responsiveness in primary pulmonary hypertension. Circulation 1990;82:2018-26.
10. Adnot S, Defouilloy C, Andrivet P, Kouyoumdjian C, Sediame S, Herigault R, et al. Hemodynamic and gas exchange responses to infusion of acetylcholine and inhalation of nitric oxide in patients with chronic obstructive lung disease and pulmonary hypertension. Am Rev Respir Dis 1993;148:310-6.
11. Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 1995;333:214-21.
12. McQuillan L, Leung G, Marsden P, Kostyk S, Kourembanas S. Hypoxia inhibits expression of NOS via transcriptional and posttranscriptional mechanisms. Am J Physiol 1994; 36:H1921-7.
13. Kouyoumdjian C, Adnot S, Levame M, Eddahibi S, Boussba H, Raffestin B. Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats. J Clin Invest 1994; 94:578-84.